Type II Interferon (IFN)-γ acts on tumor cells, enhancing their recognition by CD8+ T cells as well as by CD4+ T cells, and unveiling a key role in the promotion of tumor immunogenicity [33]. The gene discussed is CD4; the disease is neoplasm.